European Access Academy

A multi-stakeholder initiative aiming to facilitate and support the development of a joint European value framework for the assessment of innovative health technologies

The European Access Academy (EAA) aims to identify key challenges and provide sound input for the implementation of the EU HTA Regulation to help achieve the EC’s mission of improving patient access to life saving innovative technologies.


The EAA Faculty is acting as Steering Committee for the EAA's work, providing guidance on strategy, supporting peer-reviewed publications and ensuring scientific integrity. As such, it is listed in the EU Transparency Registry and was accepted as a member of the European Commission's  HTA Stakeholder Network.


EAA Spring Convention 2026:


Cross-Functional Interface &

Approaching the Revision of the

EU HTA Regulation

THANK YOU!


Once again, the EAA Convention (co-hosted by Cancer Patients Europe (CPE) and European Hematology Association (EHA)) was packed with insights-filled and thought-provoking presentations, with heated, at times controversial and always constructive discussions, and excellent side conversations before and after the sessions.

Both topics covered, the interface of the EUHTA Regulation with other EU initiatives and legislation, as well as kicking off preparations for the revision of the EUHTAR by developing suggestions for stakeholder-centric amendments to address key challenges, are important steps for a successful implementation of a balanced European HTA system, that provides a real "additional benefit".

A huge THANKS to:
- Vlerick Business School and Walter Van Dyck, and RIZIV-INAMI and Marc Van de Casteele for hosting the convention
- all our speakers (Francis Arickx, Tomislav Sokol, Valentina Barbuto, Fabio D'Atri, Alexander Natz, Anne Willemsen, Solène Jouan, Étienne Lengliné, Marc Van de Casteele, James Ryan, Marcus Guardian, Dominik Roters, Walter Van Dyck)
- the session moderators (Antonella Cardone, Robin Doeswijk, Marc Van de Casteele, Walter Van Dyck)
- all participants for their valuable input

- the excellent technical team from BMK MEDIA GROUP with Thomas Beer, without whom the great event & livestream wouldn't be possible
- CPE and EHA for co-hosting the convention
- the EAA sponsors for supporting and our excellent faculty guiding all EAA's activities.

The video recordings and resources of the convention will be available at the EAA website soon - watch this space for updates.


SAVE the DATE for the EAA Fall Convention: November 19/20 at INFARMED in Lisbon.


EAA News & Media Posts - Archive


December 11, 2025: A Pulse Check on EU HTA - Status at the End of Year One

December 8, 2025: EAA Comment on Risk of Type 2 Error in IQWiG's Assessment of Lecanemab

December 4, 2025: EAA Comment on HTACG Annual Work Programme for 2026

November 27, 2025: Memorial Symposium for Prof. Dr. Friedrich Wilhelm Schwartz, the "father of public health in Germany"

July 1st & 2nd, 2025: DG Santé Events on EU HTA in Brussels

The EAA would like to commend Maya Matthews and DG Santé for organizing exciting days on EU HTA in Brussels.

June 23, 2025: EAA Presentations at API-CCS event in Paris

Download the slides that were presented by the EAA Secretariat:

November 25, 2024: Open Letter from the EAA Faculty to the HTACG and DG Santé on the EU HTA Methods Guidance Documents

November 19, 2024: EAA Faculty Feedback on the Draft Implementing Act on JSC for Medical Devices

October 22, 2024: EAA Faculty Feedback on the Draft Implementing Act on JSC


June 25, 2024: EAA Faculty Feedback on the Draft Implementing Act on CoI


June 19, 2024: EAA Presentation at HTAi in Sevilla, Spain


April 14, 2024: EAA Faculty Statement on HTA CG Methodological Guideline for Treatment Comparisons


April 2, 2024: EAA Faculty Feedback on the Draft Implementing Act on JCA


Feb 19, 2024: EAA Post: 'Uncertainty - Friend or Foe'


Feb 06, 2024: EAA Post regarding 'Roadblocks' for EU HTA


Jan 15, 2024: EAA Post regarding the EU HTA Implementing Acts


Topical Collection at the Journal of Market Access and Health Policy on EU HTA:


The European Access Academy (EAA) and the Market Access Society (MAS) are editing a Topical Collection at JMAHP focusing on EU HTA, with Jörg Ruof and Mondher Toumi as guest editors. The goal of the Collection is to generate a comprehensive resource consolidating relevant information and diverse perspectives from various stakeholders and a range of focus topics regarding EU HTA.


Access the Collection HERE directly at the journal or find a list of all articles in this collection HERE.

New Manuscript: Legal implications of joint clinical assessments under the EU HTA regulation


With the first JCA procedures well under way a variety of challenges have been discussed but the legal implications of practically relevant issues remain to be explored in more detail. This excellent manuscript, developed as part of the ASCERTAIN project, investigates legal aspects of PICO disparities, Conflict of Interest management, uptake of JCA reports and consequences for patient access. A highly recommended read for anyone interested in EU HTA!